The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for ViOptix sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Vioptix Inc (Vioptix) is a medical device company, that discovers and develops monitoring and diagnostic equipment. The company manufactures, designs, markets, and develops non-invasive local tissue oxygen measuring devices. Its products portfolio include tissue oximeter, remote and sensor devices. Vioptix’s system uses near-infrared spectroscopy to provide continuous real-time tissue oxygen saturation measurements. The company’s products find applications in estimation of wound healing potential, determination of amputation level, plastic surgery, breast cancer, neonatology, melanoma, and critical care, among others. Its products are also used for diagnostic imaging, clinical monitoring, vascular assessment, and ischemia evaluation. The company serves clinicians and patients. Vioptix is headquartered in Newark, California, the US.
The key metrics of ViOptix related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As ViOptix is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as ViOptix.
For a detailed understanding of the performance of ViOptix, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
